Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,

Slides:



Advertisements
Similar presentations
Down Alert Function of the GlucoWatch® G2 TM Biographer (GW2B) During Insulin- induced Hypoglycemia in Children Eva Tsalikian 1, Craig Kollman 2, Rosanna.
Advertisements

INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS
National Diabetes Statistics Report Fun Facts on Diabetes 29.1 million people or 9.3% of the US population have diabetes. Diagnose : 21.0 million people.
Diabetes Self-Management Profile- Revised for Conventional and Flexible Insulin Regimens Wysocki, T. 1, Xing, D. 2, Fiallo-Scharer, R. 3, Doyle, E. 4,
Area 4 SHARP Face-to-Face Conference Phenotyping Team – Centerphase Project Assessing the Value of Phenotyping Algorithms June 30, 2011.
Continuous Glucose Monitoring. Diabetes Management Evolution Insulin Delivery Glucose Monitoring 2000 First CGM system 2006 Paradigm REAL- Time, combining.
1 GLUCOWATCH ® G2™ BIOGRAPHER H. PETER CHASE, MD I)INTRODUCTION II)ACCURACY DATA III) HOME PILOT TRIAL IV) DIRECNET STUDY GROUP V) SUMMARY.
Insulin Pump What to tell your patient!! Prakash Abraham Isla Fairley.
Ambulatory Blood Pressure Profiles in Adolescents with Type 1 Diabetes Andrew J. Ellis 1,2, B.A.; David M. Maahs 2, M.D. Ph.D.; Franziska K. Bishop 2,
Determination of System Equivalency – TaskForce Audi, EA-52, V4.0 WLTP-10-33e.
Diabetes Control in Youth: The American Experience Georgeanna J. Klingensmith, MD Keystone Colorado July 2008.
DAVID C KLONOFF, MD Medical Director Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services Clinical Professor of.
Diabetes Update: Living Life after Lente
1 INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS H. Peter Chase, MD Vicky Gage, RN, CDE Laurel Messer, RN, CDE Susie Owen, RN, CDE Sally Sullivan, RN, CDE.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J CLIN ENDOCRINOL METAB, 97, , 2012.
1 Progress Towards an Artificial Pancreas for T1D WILLIAM TAMBORLANE, MD Chief of Pediatric Endocrinology, Yale University, Deputy Director, Yale Center.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
Accuracy of the A1cNow ® in Children with T1D. Diabetes Research in Children Network Larry Fox, 1 Dongyuan Xing, 2 Katrina Ruedy, 2 Roy Beck, 2 Craig Kollman,
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the Feasibility of Computer-Based Data Acquisition and Transmission.
Sugar control in Critical care unit Senior clinical pharmacist : Lihua Fang Koo Foundation Cancer Center.
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.
Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus Matthew Faiman.
4-06 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient TEAM MEMBERS: Physicians: Maryann Emanuele,
Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
© Copyright 2009 by the American Association for Clinical Chemistry Glucose Meter Performance Criteria for Tight Glycemic Control Estimated by Simulation.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Marta Alves, Celestino Neves, Ana Varela, Cristina Arteiro, Luís Miguel Pereira, Davide Carvalho, José Luís Medina. Endocrinology Service, S. João Hospital,
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson,
Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
Reliability of two indices of the biologic variability in glycosylation among children and adolescents with T1DM Darrell M Wilson 1, Rosanna Fiallo-Scharer.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Comparison of Modified ETDRS and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema Sponsored by the National Eye Institute,
Effectiveness of Early Intensive Therapy On β-Cell Preservation in Type 1 Diabetes Featured Article: Bruce Buckingham, M.D., Roy W. Beck, M.D., P.H.D.,
Healthcare Across Borders - September 2003 Head-To-Head Comparison Of The Two Currently Available Continuous Monitors North County Endocrine 700 West El.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free- Living, Randomized Clinical Trial Featured Article: Roman Hovorka,
Alterations in White Matter Structure in Young Children With Type 1 Diabetes Featured Article: Naama Barnea-Goraly, Mira Raman, Paul Mazaika, Matthew Marzelli,
Performance of the DCA 2000 ® + Analyzer for Measurement of Hemoglobin A1 c Levels in Children with T1DM in a DirecNet Outpatient Clinical Trial.
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
Interobserver Reliability of Acute Kidney Injury Network (AKIN) criteria A single center cohort study Figure 2 The acute kidney injury network (AKIN) criteria.
Hypothesis Testing Errors. Hypothesis Testing Suppose we believe the average systolic blood pressure of healthy adults is normally distributed with mean.
Tresiba- insulin degludec
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,
Diabetic Profile Measurement of Blood Glucose T.A. Bahiya Osrah.
TEMPLATE DESIGN © CONTINUOUS GLUCOSE MONITORING, ORAL GLUCOSE TOLERANCE, AND INSULIN – GLUCOSE PARAMETERS IN ADOLESCENTS.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
Daniel A. Baur, Fernanda S. Vargas, Jordan A. Garvey, Christopher W. Bach, and Michael J Ormsbee, FACSM Institute of Sports Sciences and Medicine, Department.
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Introduction to Quality Assurance. Quality assurance vs. Quality control.
17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study David B. Nelson, MD; Donald D. McIntire,
DRCR Retina Network Treatment for Center-Involved DME in Eyes with Good Visual Acuity (Protocol V)
Intranasal Glucagon Investigators
Presentation transcript:

Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center, and representatives form NICHD and NIDDK Objective: to critically evaluate the clinical usefulness of current and future glucose sensors in youth with TIDM

Background: CGMS Accuracy Study CGMS was first FDA approved sensor Has been used to characterize glucose profiles in children by many investigators Most CGMS validation studies were performed with adults and used comparisons to meter instead of reference laboratory serum glucose levels Recent reports have questioned accuracy and reproducibility of CGMS readings

Objective To assess the accuracy of the CGMS inc children and adolescents with type 1 diabetes when compared with reference serum glucose levels Examined accuracy under three conditions:  Spontaneous fluctuations in 24 hour period  Acute hyperglycemia (1.75gm/kg CHO liquid meal)  Acute hypoglycemia ( u Regular insulin intravenous bolus)

Methods: Overall Subjects were admitted to the CRC for hrs IV catheter was inserted to obtain serum glucose levels to be measured by central lab Blood samples were obtained every 60 min during the day, and every 30 min during the night (930p- 630a) Blood samples were also obtained with symptomatic hypoglycemia (if FS < 65 mg/dL) Skin assessment at time of discharge and in 3-5 days following discharge

Methods: CGMS CGMS were inserted by study staff either on day of admission or 1-2 days prior to admission to assess full 72 hour life of sensor Four fingerstick blood sugars done with a One Touch Ultra meter were entered into the CGMS for calibration Sensors were replaced if they failed Simultaneous use of a second CGMS was offered as an option. Sensors were inserted into abdomen or buttucks

Statistical Methods: CGMS Measurements CGMS glucose measurements were matched to reference measurements from blood samples drawn within 2.5 min of each other CGMS time was adjusted by 2.5 min to account for averaging of glucose levels made over the previous 5 min When comparing CGMS monitors simultaneously, sensor values were matched within 2.5 min of each other

Statistical Methods: Modified Sensors During the course of the study, Medtronic MiniMed changed the manufacturing process of the sensor that had been in place since 1999 Sensor fabrication process was modified Accuracy analyses were conducted separately with the “original” and “modified” sensors

Subjects ( N= 91) Mean age: yrs Gender: 45 M, 46 F Race: 85% White Duration T1DM: yr Mean HbA1c = % Injections (57%) Pump (43%) Diabetes Therapy

Sensor Function Day of sensor insertion Percent (%) ** 6% of all possible readings were skipped (N/A)

CGMS Accuracy Summary Statistics (N = 6,778 sensor reference pairs) Mean (95% confidence interval) Median (25 th, 75 th percentiles) Difference mg/dL -2.9 (-8.0, 2.1)2 (-27, 28) Absolute difference mg/dL 38.0 (34.7, 41.7)28 (12,50) Relative difference4% (1%, 8%)2% (-16%, 20%) Relative absolute difference 25% (23%, 27%)18% (8%, 34%)

Original vs Modified Sensors Comparison of Accuracy Relative Absolute Difference (median) (25 th, 75 th percentiles) 19% (9%, 36%) 11% (5%, 23%) <0.001 Modified Clarke Error Grid Zone A (percentage) 58%78%<0.001 Modified Clarke Error Grid Zone A+B (percentage) 93%98%<0.001 Original Sensors Modified Sensors P-Value N=5,658 Paired Values N=1,120 Paired Values

Original vs Modified Sensors Comparison of Accuracy ISO Criteria † Met According to Reference Glucose Level Percent (%)  70 mg/dL mg/dL mg/dL mg/dL >240 mg/dL All Values Original Sensors N=5,658 Paired Values Modified Sensors N=1,120 Paired Values * P<.05 ** P<.001 ISO for Ultra Meter = 94% † ISO criteria: for reference BG ≤75 mg/dL, SG within ±15 mg/dL for reference BG >75 mg/dL, SG value within ±20% * * * **

Original vs Modified Sensors Comparison of Accuracy – Variation Among Sensors Original Sensors Modified Sensors P-Value N=112 Sensors* N=25 Sensors* Sensors with Median RAD<10% Sensors with Median RAD<20% Sensors with Median RAD<30% Sensors with  80% of Values Meeting ISO Criteria Sensors with  60% of Values Meeting ISO Criteria 9% 54% 80% 9% 35% 36% 88% 100% 24% 80% 0.01 < <0.001 * Sensors were included if they had at least 10 paired readings

Original vs Modified Sensors: Precision of 2 Simultaneous CGMS Original SensorsModified Sensors # Paired Data Points13,6695,021 Absolute Difference median mg/dL (25 th, 75 th percentiles) 28 (12,55) 17 (7,34) Relative Absolute Difference median (25 th, 75 th percentiles) 17% (7%, 33%) 10% (4%, 20%) Values within 10% percentage32%50% Values within 20% percentage55%76% Pearson Correlation

Conclusions Sensors were tolerated well by children aged 3-17, and there were no adverse events Most sensors functioned for full three days Overall percentage of skipped readings was low

Conclusions: Original Sensors Original sensors were frequently inaccurate in detecting glucose excursions and detecting hypoglycemia  Accuracy was better during hyperglycemia than during hypoglycemia Precision (comparing two CGMS worn simultaneously) was poor (r =.77)

Conclusions: Modified Sensors Modified sensors were more accurate on all measures Modified sensors had better precision (r =.92) Further research is necessary to determine if detection of hypoglycemia will be better with the modified sensors

Barbara Davis Center –H. Peter Chase –Rosanna Fiallo-Scharer –Jennifer Fisher University of Iowa –Eva Tsalikian –Michael Tansey –Linda Larson Nemours Children’s Clinic –Tim Wysocki –Nelly Mauras –Kristen Gagnon University of Minnesota Central Lab –Michael Steffes –Jean Bucksa –Maren Nowicki Stanford University –Bruce Buckingham –Darrell Wilson –Jennifer Block Yale University –William Tamborlane –Stuart Weinzimer –Elizabeth Boland Jaeb Center for Health Research –Roy Beck –Katrina Ruedy –Craig Kollman –Andrea Booth –Gladys Bernett